Correlation of serum paraoxonase activities in known cases of 130 elderly hypertensive South Asian aged 56-64 years - a hospital based study

Asian Pacific Journal of Tropical Disease

Volumn 4, Issue S1, 2014, Pages

  Kumar, Arun ^a  

^a MANAGEMENT AND SCIENCE UNIVERSITY   (Malaysia)

Author keywords

Antioxidants; Hypertension; Oxidative Stress; Paraoxonase; South Asian

Indexed keywords

ALBUMIN; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; BILIRUBIN; CATALASE; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERTENSION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECKNAGEL AND GLENDE METHOD; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84893508897     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(14)60465-5     Document Type: Article

References (42)

1. Baruah MP, Kalra S, Unnikrishnan AG Endocrine hypertension: changing paradigm in the new millennium. Indian J Endocrinol Metab 2011, 15(Suppl 4):S275-S278.
2. World Heart Federation Hypertension and cardiovascular disease. Geneva: World Heart Federation. [Online] [Accessed on 12th November, 2013]. http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/hypertension/.
3. Caballero E, Santos KB, Osorio LR, Montagnani V, Soodini G, Porramatikul S, et al. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care 2008, 31:576-582.
4. Abebe W, Mozaffari MS Role of taurine in the vasculature:an overview of experimental and human studies. Am J Cardiovasc Dis 2011, 1(3):293-311.
5. Grossman E Does increased oxidative stress cause hypertension?. Diabetes Care 2008, 31(Suppl 2):S185-S189.
6. Kumar A, Sivakanesan R, Gunasekera SW Oxidative stress and antioxidant status in normolidemic AMI Patients. Indian J Clin Biochem 2008, 23(3):296-298.
7. Assadpoor-Piranfar M, Pordal AH, Beyranvand MR Measurement of oxidized low-density lipoprotein and superoxide dismutase activity in patients with hypertension. Arch Iran Med 2009, 12(2):116-120.
8. Gönenc A Oxidized low-density protein, interleukin-6 and tumor necrosis factor alpha levels and paraoxonase activities in hypertensive patients. Turk J Pharm Sci 2012, 9(1):41-50.
9. Basati G, Pourfarzam M, Movahedian A, Samsamshariat ZS, Sarrafzadegan N Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients. Clinics (Sao Paulo) 2011, 66(7):1129-1135.
10. Schrijvers DM, De Meyer GR, Herman AG, Martinet W Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 2007, 73:470-480.
11. Catagol B, Ozen NK Lipid rafts and redox regulation of cellular signalling in cholesterol. Curr Cardiol Rev 2010, 6:309-324.
12. Kumar A, Sivakanesan R, Nagtilak S Serum paraoxonase activity in normolipidaemic patients with acute myocardial infarction. J Clin Diagn Res 2008, 2:1052-1056.
13. Kumar A, Biswas UK Smoking is associated with reduced serum paraoxonase, antioxidants and increased oxidative stress in normolipidaemic acute myocardial infarct patients. Heart Asia 2011, 3:115-119.
14. Khan MS, Khan A, Iqbal J Effect of dietary tocotrienols on infection and inflammation induced lipoprotein oxidation in hamsters. Int J Pharm Pharm Sci 2011, 3(3):277-284.
15. Rodríguez Esparragón F, Hernández Trujillo Y, Macías Reyes A, Hernández Ortega E, Medina A, Rodríguez Pérez JC [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis]. Rev Esp Cardiol 2006, 59:154-164. Spanish.
16. Gupta N, Singh S, Maturu VN, Sharma YP, Gill KD Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting CAD risk in North-West Indian Punjabis. PLoS ONE 2011, 6(5):17805.
17. Agrawal S, Tripathi G, Prajnya R, Sinha N, Gilmour A, Bush L, et al. Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians. Indian J Med Sci 2009, 63:335-344.
18. Zhong JK, Gua ZG, Li C, Wang ZK, Lai WY, Tu Y Probucol alleviates atherosclerosis and improves high density lipoprotein function. Lipids Health Dis 2011, 10:210.
19. Camps J, García-Heredia A, Rull A, Alonso-Villaverde C, Aragonès G, Beltrán-Debón R, et al. PPARs in regulation of paraoxonases; control of oxidative stress and inflammation pathways. PPAR Res 2012, 10.1155/2012/616371.
20. Akbas HS, Basyigit S, Suleymanlar I, Kemalogu D, Koc S, Davran F, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in helicobacter pyroli positive subjects. Lipids Health Dis 2010, 9:92.
21. McGrowder D, Riley C, Morrison EY, Gordon L The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011, 10.1155/2011/496925.
22. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Eng J Med 2011, 365(24):2255-2267.
23. Manfredini V, Biancini GB, Vanzin CS, Dal Vesco AM, Cipriani F, Biasi L, et al. Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients. Cell Biochem Funct 2010, 28(5):360-366.
24. Rose GA, Blackburn H, Gillum RF, Prineas RJ Cardiovascular survey methods 1982, World Health Organisation, Geneva. 2nd ed.
25. Paglia DE, Valentine WN Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
26. Sun Y, Oberly LW, Li Y A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-500.
27. Beutler E Red cell metabolism: a manual of biochemical methods 1984, 105. Grune and Stratton, New York. 3rd ed.
28. Beutler E, Duron O, Kelly B An improved method for the determination of blood glutathione. J Lab Clin Med 1963, 61:882-888.
29. Haagen L, Brock A A new automated method of phenotyping arylesterase (EC 3.1.1.2) based UPON1 Inhibition of enzymatic hydrolysis of 4-nitrophenol acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992, 30:391-395.
30. Tartan Z, Orhan G, Kasikçioglu H, Uyarel H, Unal S, Ozer N, et al. The role of paraoxonase (PON1) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients. Heart Vessels 2007, 22:158-164.
31. Bernheim F, Bernheim ML, Wilbur KM The reaction between thiobarbituric acid and the oxidant product of certain lipids. J Biol Chem 1948, 174:257-264.
32. Recknagel RO, Glende EA Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 1984, 105:331-337.
33. Brown H The determination of uric acid in human blood. J Biol Chem 1945, 158:601-608.
34. McPhaul L, Kershaw M, Tilque D, Eckfeldt JH A 2,4-dichlorophenyl diazonium-based method for total bilirubin without interference from indican in uremic sera. Clin Chem 1985, 31(7):1229-1231.
35. Perry BW, Doumas BT Effect of heparin on albumin determination by use of bromocresol green and bromocresol purple. Clin Chem 1979, 25:1520-1522.
36. Roe JH, Kuether CA The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 1943, 147:399-407.
37. Cachofeiro V, Miana M, Heras ND, Fernandez BM, Ballesteros S, Balfagon G, et al. Inflammation: a link between hypertension and atherosclerosis. Curr Hypertens Rev 2009, 5:40-48.
38. Tang WH, Wu Y, Mann S, Pepoy M, Shrestha K, Borowski AG, et al. Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure. Circ Heart Fail 2011, 4:59-64.
39. Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK, et al. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis 2011, 71(7):1157-1162.
40. Bodolay E, Seres I, Szodorav P, Csipo I, Jakab Z, Vegh J, et al. Evaluation of paraoxonase activity in patients with mixed connective tissue disease. J Rheumatol 2008, 35(2):237-243.
41. Prakash M, Phani MM, Kavya R, Supriya M Paraoxonase: its antiatherogenic role in chronic renal failure. Indian J Nephrol 2010, 20(1):9-14.
42. Sheweita SA, Baghdadi H, Allam AR Role of genetic changes in the progression of cardiovascular diseases. Int J Biomed Sci 2011, 7(4):238-248.